-+ 0.00%
-+ 0.00%
-+ 0.00%

Ultragenyx Pharmaceutical Eliminating ~20% Employees

Benzinga·11/03/2026 21:09:13
Listen to the news

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced it is reducing headcount by approximately 20%, resulting in a revised workforce of approximately 1,000 employees.